Skip to main content
OpenTrials
Completed

NCT Number: NCT00682825

Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia

The overall purpose of this study is to see if a Bispectral Index (BIS) monitor, a Food and Drug Administration (FDA) approved brain monitoring device, will help to reduce the risk of patients remembering being awake during surgery. The BIS monitor may be able to measure how asleep a patient is during surgery. Using the BIS monitor to guide anesthesia will be compared with using the concentration of anesthetic gas to guide anesthesia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

University of Manitoba, Winnipeg, Manitoba, Canada

Loading trial locations.

About this study

The incidence of anesthesia awareness (AA) is 0.1-0.2% and may result in post traumatic stress disorders. For some patients, owing to illness, medications, substance misuse or surgery, the risk approaches 1%. The B-AWARE Study by Myles et al. suggested that the bispectral index (BIS) monitor, which reportedly reflects anesthetic depth, may decrease the incidence of AA in higher risk patients by 82%. The American Society of Anesthesiologists has published a practice advisory on AA, which does not recommend the routine use of cerebral function monitors. We propose to test the hypothesis that an anesthetic protocol based on BIS decreases the incidence of AA among higher risk patients compared with an anesthetic protocol based on the end-tidal anesthetic gas (ETAG) concentration. We have completed a randomized, single-blinded prospective feasibility study (The B-Unaware Trial) which enrolled 2000 patients at higher risk for AA. Four patients (0.21%; 95% CI=0.06% to 0.57%) had definite AA, of whom two were in the BIS-guided group and two in the ETAG-guided group. Nine patients (0.46%; 95% CI=0.22% to 0.91%) had definite or possible AA, of whom six were in the BIS-guided group and three in the ETAG-guided group. The BAG RECALL study will be a multi-center, prospective, single-blinded, randomized study enrolling 6000 patients at higher risk for AA. The BAG RECALL study is adequately powered and rigorously designed to answer with a reasonable degree of scientific probability whether BIS guidance results in clinically relevant reduction in anesthesia awareness among higher risk patients undergoing general anesthesia.

At the University of Michigan, a parallel study will be conducted - Michigan Awareness Control Study, MACS (NCT00689091) - enrolling 30,000 patients to assess whether the BIS monitor decreases the likelihood of anesthesia awareness among all patients undergoing general anesthesia, regardless of their risk profile. The investigators of this study and the BAG-RECALL study have collaborated in designing these studies and are pre-specifying that common outcome measures will be examined collaboratively including data from both studies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

MUST HAVE:

General Anesthesia with volatile anesthetic

PATIENT CHARACTERISTICS

Major Criteria (Must have any 1 of the following:)

  • Planned open heart surgery
  • Medications - anticonvulsants, abuse of opiates, benzodiazepines, cocaine
  • EF<40%
  • Prior history of awareness (recall)
  • History of difficult intubation or anticipated difficult intubation
  • ASA IV or V status
  • Aortic stenosis
  • End stage lung disease
  • Marginal exercise tolerance not secondary to musculoskeletal dysfunction
  • Pulmonary hypertension
  • Daily alcohol consumption

Exclusion criteria

  • Surgical procedure that prevents the use of the BIS (e.g. surgery of forehead)
  • Patient positioning prevents use of the BIS
  • Surgery with wake-up test.
  • Less than 18 years of age
  • Vulnerable populations, such as those with dementia and those unable to provide informed consent.
  • Stroke with residual neurological deficits

-

Treatment and study plan

Bispectral index protocol

Behavioral

Aim to titrate anesthesia to maintain BIS between 40 and 60.

End tidal anesthetic gas-guided

Behavioral

Aim to maintain anesthetic gas between 0.7 and 1.3 MAC equivalents

Primary outcomes

  1. The incidence of explicit recall of events during the surgical and anesthetic periods.

    Time frame: Three years

Secondary outcomes

  1. Meta-analysis for anesthesia awareness incorporating higher risk patients from the completed B-Unaware Trial (NCT00281489), the BAG-RECALL Trial, and the Michigan Awareness Control Study (MACS)(NCT00689091).

    Time frame: Three years

  2. Incidence of post-traumatic stress disorder (PTSD).

    Time frame: Five years

  3. Association between type of awareness event and PTSD, and whether the PTSD is associated with late reporting (30 days) of awareness.

    Time frame: 5 years

  4. Types of dreams and their relationship to BIS and ETAG.

    Time frame: Three years

  5. The relationship between deep hypnotic time, anesthetic dose (MAC), mean arterial pressure, and end tidal carbon dioxide, and early (one-month) and late (one-year) mortality.

    Time frame: Four years

  6. Relationship between BIS, heart rate and blood pressure.

    Time frame: Three years

  7. Relationship between BIS and anesthesia dose and concentration.

    Time frame: Three years

  8. Association between baseline BIS values, patient health and early (one-month) and late (one-year) mortality.

    Time frame: Four years

  9. Interaction between hemispheric dominance and BIS.

    Time frame: Three years

  10. Effect of red hair phenotypes on the relationship between ETAG and BIS.

    Time frame: Three years

  11. Refinement of risk factors for anesthesia awareness.

    Time frame: Three years

  12. Relationship between rising BIS in the PACU and first memory after surgery.

    Time frame: Three years

  13. Postoperative delirium.

    Time frame: Three years

  14. BIS and mixed venous saturation.

    Time frame: Three years

  15. Induction of anesthesia and hypotension.

    Time frame: Three years

  16. Incidence of postoperative nausea and vomiting.

    Time frame: Three years

  17. Incidence of and severity of postoperative pain.

    Time frame: Three years

  18. Effect of BIS and ETAG protocols on time to open eyes, time to extubation, and time spent in the postoperative recovery unit.

    Time frame: Three years

  19. Effect of a defasciculating dose of a non-depolarizing muscle relaxant on BIS.

    Time frame: Three years

  20. The effect of patient temperature on BIS.

    Time frame: Three years

  21. Incidence of recall of traveling to the OR among patients who receive midazolam in the holding area and whose initial BIS reading in the OR is > 60.

    Time frame: Three years

  22. Relationship between BIS, ETAG and EEG parameters.

    Time frame: Three years

  23. Annual assessment of practitioners' abilities to interpret BIS tracings and to identify artefacts.

    Time frame: Three years

  24. Differences in anesthesia practice among four institutions in the USA and Canada as judged by anesthetic doses and BIS readings.

    Time frame: Three years

  25. Effect of BIS and ETAG protocols on anesthetic dose administration and on BIS readings.

    Time frame: Three years

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • American Society of Anesthesiologists
  • Foundation for Anesthesia Education and Research
  • University of Chicago
  • University of Manitoba
  • University of Michigan

Registry information

Official study title

BAG-RECALL Study: BIS or Anesthesia Gas to Reduce Explicit Recall

Acronym: BAG-RECALL

Important dates

Study start
2008
Primary completion
2010
First posted
May 22, 2008
Registry last updated
Jan 4, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.